MBCC

Patricia Jakel, RN, MN, AOCN, On Treating Patients with CDK 4/6 Inhibitors
March 15, 2020

The clinical nurse specialist was also diagnosed with stage III invasive lobular breast cancer and was treated with CDK 4/6 inhibitors, giving her the unique opportunity to speak to both the patient and clinical perspective.

Enrique Soto Perez de Celis, MD, MSc, On Treatment for Older Women with TNBC
March 14, 2020

The geriatric oncologist spoke about the differences in treating older women and younger women with triple-negative breast cancer.

Debu Tripathy, MD, On the Future of Triple Negative Breast Cancer Treatment
March 13, 2020

The breast medical oncologist discussed new treatment options for triple negative breast cancer as new targets become readily available for this aggressive cancer type.